KBP-336

KBP-336 · KeyBioscience AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KBP-336, covering 2025-02-19 to 2025-02-19. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis [Phase 2]